Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer Patients-Reference-Cited by-同舟云学术

Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer Patients

Published:2020-12-06 Issue:5 Volume:109 Page:1304-1313
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Man Femke M.¹,Eerden Ruben A.G.¹,Doorn Gerdien M.²,Oomen‐de Hoop Esther¹,Koolen Stijn L.W.¹³,Olieman Joanne F.²,Bruijn Peter¹,Veraart Joris N.¹,Halteren Henk K.⁴,Sandberg Yorick⁵,Moelker Adriaan⁶,IJzermans Jan N.M.⁷,Lolkema Martijn P.¹,Gelder Teun³,Dollé Martijn E.T.⁸,Bruin Ron W.F.⁷,Mathijssen Ron H.J.¹

Affiliation:

1. Department of Medical Oncology Erasmus MC Cancer Institute Rotterdam The Netherlands

2. Department of Internal Medicine Erasmus MCUniversity Medical Center Rotterdam The Netherlands

3. Department of Hospital Pharmacy Erasmus MCUniversity Medical Center Rotterdam The Netherlands

4. Department of Internal Medicine Admiraal de Ruyter Hospital Goes The Netherlands

5. Department of Internal Medicine Maasstad Hospital Rotterdam The Netherlands

6. Department of Radiology Erasmus MCUniversity Medical Center Rotterdam The Netherlands

7. Department of Surgery Erasmus MCUniversity Medical Center Rotterdam The Netherlands

8. Centre for Health Protection Research National Institute for Public Health and Environment (RIVM) Bilthoven The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2094

Reference37 articles.

1. Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics

2. Clinical pharmacokinetics and metabolism of irinotecan (CPT‐11);Mathijssen R.H.;Clin. Cancer Res.,2001

3. Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice

4. Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice

5. Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of nutritional interventions reducing calories, a systematic scoping review;Clinical Nutrition ESPEN;2024-10

2. Population pharmacokinetics of intraperitoneal irinotecan and SN‐38 in patients with peritoneal metastases from colorectal origin;CPT: Pharmacometrics & Systems Pharmacology;2024-04-17

3. Diätetische Ansätze in der Tumortherapie;TumorDiagnostik & Therapie;2024-03-27

4. Efficiency of Protective Interventions on Irinotecan-Induced Diarrhea: A Systematic Review and Meta-Analysis;Integrative Cancer Therapies;2024-01

5. Take metabolic heterogeneity into consideration when applying dietary interventions to cancer therapy: A review;Heliyon;2023-12